EAACI Portal

Eaaci: European Academy of Allergy and Clinical Immunology

UPCOMING EVENTS

    SAM Digital 2021, Skin Allergy Meeting - Joint meeting with ESCD
    12 - 13 March 2021
    Digital Event
    ISAF Digital 2021, International Severe Asthma Forum
    17 April 2021
    Digital Event
    PAAM Digital 2021, Pediatric Allergy and Asthma Meeting
    12 - 13 November 2021
    Digital Event
    Save the date
ALL, PAI & CTA
Journals
EAACI Guidelines
Guidelines
Global Atlases
Books
Overview of active Task Forces
Task Forces
All webcasts from EAACI Meetings
Webcasts
Visit the EAACI Media Library
Media Library
All EAACI news
Newsletter
Important EAACI publications
Position Papers
EAACH Hybdrid Congress 2021: Registration open!
11452m3Share
Early bird registration is now open for the EAACI Hybrid Congress 2021, our annual meeting taking place virtually on the innovative EAACI Congress & Events Digital Platform and physically at the ICE Krakow, Poland, between 10-12 July 2021. Our annual meeting will provide an engaging and interactive forum to the Allergy and Clinical Immunology scientific community, gathering to discuss the latest developments around "Harmonizing Research and Patient care in Allergy Asthma and Clinical Immuno...
MyEAACI - now online!
20204m40Share
We are pleased to announce that our new My EAACI membership portal is now active. The user-friendly and effective platform was specifically tailored to help you get the most out of being an EAACI member, through the latest technology and analytics.Navigating through the My EAACI portal you can effortlessly benefit from these advanced features:- Review and update your account information from your profile- Quickly access all your invoices- Get a full overview of and manage all your EAACI Events a...
Access all our previous articles
& newsletters in PDF format.
The SAM Digital 2021 is accredited by UEMS
1742w1Share
The SAM digital 2021, Skin Allergy Meeting - Joint meeting with ESCD, Digital (originally planned in Denmark), Denmark, 12/03/2021-13/03/2021 has been accredited by the European Ac...
EAACI Hybrid Congress 2021: Submit your late abstract!
3503w3Share
Share your research at the EAACI Hybrid Congress 2021 with colleagues from around the world — both in person and through EAACI Congress Digital Platform — and extend your reach...
EAACI attends the EU Big data Stakeholder Forum
5811m2Share
Large amounts of data are generated daily through devices, electronic health records, social media, clinical trials and spontaneous adverse reaction reports. Insights derived from ...
The EMA's EU conditional marketing authorisations for COVID-19 vaccines
8052m3Share
Few medicines are awaited as eagerly as COVID-19 vaccines. Extraordinary efforts by scientists, regulators, and developers enabled the European Medicines Agency (EMA) to recommend ...
Last issue of the EAACI Newsletter
10432m28Share
Eager to get the latest news on our activities, events, task force projects and perspectives from the EAACI Family? Find them in the latest issue of the EAACI Newsletter. We would ...
Launch of EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis
11492m5Share
Atopic dermatitis imposes a significant burden on patients, families and healthcare systems. Management is difficult, due to disease heterogeneity, co‐morbidities, complexity in ...
Register now for SAM Digital 2021!
16733m5Share
The EAACI-ESCD Skin Allergy Meeting is the leading European meeting in 2021 devoted to skin allergy. The sixth edition of this biennial event will be a digital event taking place o...
Digital Launch of Recommendations "Growing up with Allergy and Asthma"
12353m5Share
The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) and the European Academy of Allergy and Clinical Immunology (EAACI) invite you to the digital...
Next
EAACI Membership 2021 - Renewal
16003m29Share
We would like to inform you that your 2021 membership renewal invoice can be accessed via our new user-friendly membership portal MyEAACI. Simply log in using your e-mail address a...
NAS - JM Position Paper Translations
13534m37Share
The EAACI NAS-JMs have translated two important EAACI position papers in your language! You can find the translations to Albanian, Bulgarian, Czech, Greek, Hungarian, Georgian, Rom...
European Parliament adopts resolution for better management of chronic diseases European Parliament adopts resolution for better management of chronic diseases
12694m2Share
The European Parliament adopted on Friday a resolution highlighting the need for a better management of chronic diseases. The adopted text is available at https://www.europarl.euro...
COVID-19 Resource Centre
14294m24Share
The EAACI community is united in disseminating new research and knowledge on COVID-19. Find some of the most useful related content on our dedicated webpage, to better serve you an...
EAACI-EFA - Statement on Europe’s Beating Cancer Plan
13384m2Share
(EAACI) and the European Federation of Allergy and Airways Diseases Patients' Associations (EFA), the two organisations coordinating the Secretariat of the European Parliament Inte...
Previous
Privacy Policy - disclaimer

EAACI recently updated its privacy policy and would like to highlight some key bits of information with you.

  • EAACI does not distribute, share or sell your information;
  • For technical and administrative purposes some information that can be used to identify you may be forwarded to third parties. For example, to process your registration for the EAACI Annual Congress and other EAACI events;
  • The Academy may also send you e-mail messages with news from the society. If you would like to no longer receive them, you can unsubscribe at any time by using the unsubscribe link in any of our communications;
  • You may also update your preferences or your profile information at any time by contacting us.

To continue please confirm that you agree with our updated privacy policy.

Thank you!

You have successfully agreed the new privacy policy – disclaimer.

Thank you!

You disagreed with the new privacy policy – disclaimer and your feedback will be reviewed as soon as possible.

Agree & Continue
Disagree
Send feedback
Cancel